Marshall & Sterling Wealth Advisors Inc. Abbott Laboratories Transaction History
Marshall & Sterling Wealth Advisors Inc.
- $148 Billion
- Q2 2025
A detailed history of Marshall & Sterling Wealth Advisors Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Marshall & Sterling Wealth Advisors Inc. holds 210 shares of ABT stock, worth $26,239. This represents 0.02% of its overall portfolio holdings.
Number of Shares
210
Previous 209
0.48%
Holding current value
$26,239
Previous $27.7 Million
2.79%
% of portfolio
0.02%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding ABT
# of Institutions
3,617Shares Held
1.39BCall Options Held
9.21MPut Options Held
8.09M-
Vanguard Group Inc Valley Forge, PA173MShares$21.6 Billion0.39% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.4 Billion0.31% of portfolio
-
State Street Corp Boston, MA78.4MShares$9.79 Billion0.41% of portfolio
-
Capital International Investors Los Angeles, CA60.1MShares$7.51 Billion1.47% of portfolio
-
Capital Research Global Investors Los Angeles, CA41.8MShares$5.22 Billion1.19% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $219B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...